Concepedia

Author

Zackary M. Herbst

University of WashingtonORCID

Also Known As

Patrick, Donald A., Z. M. Herbst, Zachary Herbst, Zackary (Ari) M. Herbst, Zackary Herbst, Zackary M Herbst, Zackary M. Herbst

41

Publications

386

Citations

11

H-Index

45

Concepts

All Affiliations

University of WashingtonWomen's and Children's HospitalUniversidade Federal do Rio Grande do SulThe University of AdelaideNational MPS Society
ZM

About

Zackary M. Herbst is an author at University of Washington specializing in medicine, lysosomal storage disease, and bioanalysis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

102

2

Education

1

1

12

3

Engineering

1

1

25

4

Natural Sciences

1

1

36

5

Public Health

1

1

16

Zackary M. Herbst

×

11

Publications

291

Citations

11

H-Index

YearCitations

Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of Potential Drugs for Human African Trypanosomiasis

Donald A. Patrick, J. Robert Gillespie, Joshua McQueen,

Journal of Medicinal Chemistry

2016

58

1-Benzyl-3-aryl-2-thiohydantoin Derivatives as New Anti-<i>Trypanosoma brucei</i> Agents: SAR and in Vivo Efficacy

Andriy Buchynskyy, J. Robert Gillespie, Zackary M. Herbst,

ACS Medicinal Chemistry Letters

2017

42

Evaluation of Multiple Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I

Zackary M. Herbst, Leslie Urdaneta, Terri Klein,

International Journal of Neonatal Screening

2020

36

New Class of Antitrypanosomal Agents Based on Imidazopyridines

Daniel Gedder Silva, J. Robert Gillespie, Ranae M. Ranade,

ACS Medicinal Chemistry Letters

2017

33

Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II

Zackary M. Herbst, Leslie Urdaneta, Terri Klein,

International Journal of Neonatal Screening

2022

25

Triazolopyrimidines and Imidazopyridines: Structure–Activity Relationships and in Vivo Efficacy for Trypanosomiasis

Nagendar Pendem, J. Robert Gillespie, Zackary M. Herbst,

ACS Medicinal Chemistry Letters

2018

24

Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency

Francyne Kubaski, Alberto Burlina, Danilo Florentino Pereira,

Orphanet Journal of Rare Diseases

2022

17

Pilot study of newborn screening for six lysosomal diseases in Brazil

Francyne Kubaski, Inês Sousa, Tatiana Amorim,

Molecular Genetics and Metabolism

2023

16

Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency

Lars Schlotawa, Karolina Tyka, Matthias Kettwig,

EMBO Molecular Medicine

2023

15

Endogenous, non-reducing end glycosaminoglycan biomarkers are superior to internal disaccharide glycosaminoglycan biomarkers for newborn screening of mucopolysaccharidoses and GM1 gangliosidosis

Zackary M. Herbst, Xinying Hong, Leslie Urdaneta,

Molecular Genetics and Metabolism

2023

13

Page 1